Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 23-Apr-10 12:24 PM View:  | Hasnain Faheem President & CEO Director | Facet Biotech Corp (FACT) | 21-Apr-10 | Disposition | 102,667 | $27.00 | $2,772,010.00 | (100%) 102.67K to 0 | (< 1%) |
| 23-Apr-10 3:21 PM View: | Parkinson David Ross Director | Facet Biotech Corp (FACT) | 21-Apr-10 | Disposition | 2,500 | $27.00 | $67,500.00 | (100%) 2.5K to 0 | (< 1%) |
| 23-Apr-10 1:57 PM View: | Lyons Gary A Director | Facet Biotech Corp (FACT) | 21-Apr-10 | Disposition | 2,500 | $27.00 | $67,500.00 | (100%) 2.5K to 0 | (< 1%) |
| 23-Apr-10 3:55 PM View: | Emster Kurt von Director | Facet Biotech Corp (FACT) | 21-Apr-10 | Disposition | 1,667 | $27.00 | $45,009.00 | (100%) 1.67K to 0 | (< 1%) |
| 23-Apr-10 1:42 PM View: | Llana Ted DVP Comm'l & Corp. Dev | Facet Biotech Corp (FACT) | 21-Apr-10 | Disposition | 39,893 | $27.00 | $1,077,110.00 | (100%) 39.89K to 0 | (< 1%) |
| 23-Apr-10 2:07 PM View: | Rolfe Mark Sr. Vice Pres. and CSO | Facet Biotech Corp (FACT) | 21-Apr-10 | Disposition | 21,333 | $27.00 | $575,991.00 | (100%) 21.33K to 0 | (< 1%) |
| 23-Apr-10 12:11 PM View: | Goodwin Bradford S Director | Facet Biotech Corp (FACT) | 21-Apr-10 | Disposition | 3,334 | $27.00 | $90,018.00 | (100%) 3.33K to 0 | (< 1%) |
| 23-Apr-10 1:16 PM View: | Huh Hoyoung Director | Facet Biotech Corp (FACT) | 21-Apr-10 | Disposition | 8,333 | $27.00 | $224,991.00 | (100%) 8.33K to 0 | (< 1%) |
| 23-Apr-10 12:56 PM View: | Hora Maninder VP, Prod Ops. & Quality | Facet Biotech Corp (FACT) | 21-Apr-10 | Disposition | 13,803 | $27.00 | $372,681.00 | (100%) 13.8K to 0 | (< 1%) |
| 23-Apr-10 3:39 PM View: | Sarena Francis Willard VP Gen Counsel & Secy | Facet Biotech Corp (FACT) | 21-Apr-10 | Disposition | 16,277 | $27.00 | $439,479.00 | (100%) 16.28K to 0 | (< 1%) |
| 23-Apr-10 11:41 AM View: | Cross Herb VP of Finance | Facet Biotech Corp (FACT) | 21-Apr-10 | Disposition | 11,602 | $27.00 | $313,254.00 | (100%) 11.6K to 0 | (< 1%) |
| 23-Apr-10 11:56 AM View: | Guggenhime Andrew SVP & CFO | Facet Biotech Corp (FACT) | 21-Apr-10 | Disposition | 32,090 | $27.00 | $866,430.00 | (100%) 32.09K to 0 | (< 1%) |
| 21-Apr-10 3:54 PM View: | Rolfe Mark Sr. Vice Pres. and CSO | Facet Biotech Corp (FACT) | 20-Apr-10 | Disposition (change in control) | 1,113 | $27.00 | $30,051.00 | (5%) 22.45K to 21.33K | (< 1%) |
| 21-Apr-10 3:55 PM View: | Goodwin Bradford S Director | Facet Biotech Corp (FACT) | 20-Apr-10 | Disposition (change in control) | 10,000 | $27.00 | $270,000.00 | (75%) 13.33K to 3.33K | (< 1%) |
| 21-Apr-10 3:57 PM View: | Hora Maninder VP, Prod Ops. & Quality | Facet Biotech Corp (FACT) | 20-Apr-10 | Disposition (change in control) | 7,516 | $27.00 | $202,932.00 | (35%) 21.32K to 13.8K | (< 1%) |
| 21-Apr-10 4:00 PM View: | Sarena Francis Willard VP Gen Counsel & Secy | Facet Biotech Corp (FACT) | 20-Apr-10 | Disposition (change in control) | 9,875 | $27.00 | $266,625.00 | (38%) 26.1K to 16.23K | (< 1%) |
| 21-Apr-10 3:48 PM View: | Cross Herb VP of Finance/Prin Acctg Off | Facet Biotech Corp (FACT) | 20-Apr-10 | Disposition (change in control) | 5,281 | $27.00 | $142,587.00 | (31%) 16.88K to 11.6K | (< 1%) |
| 21-Apr-10 3:49 PM View: | Parkinson David Ross Director | Facet Biotech Corp (FACT) | 20-Apr-10 | Disposition (change in control) | 8,333 | $27.00 | $224,991.00 | (77%) 10.83K to 2.5K | (< 1%) |
| 21-Apr-10 3:57 PM View: | Llana Ted SVP Comm'l & Corp. Dev | Facet Biotech Corp (FACT) | 20-Apr-10 | Disposition (change in control) | 2,989 | $27.00 | $80,703.00 | (7%) 42.88K to 39.89K | (< 1%) |
| 21-Apr-10 5:07 PM View: | Abbott Laboratories 10% Owner | Facet Biotech Corp (FACT) | 20-Apr-10 | Market Purchase | 62,652,100 | $27.00 | $1,691,609,984.00 | 325% 19.26M to 81.91M | < 1% |
| 21-Apr-10 3:58 PM View: | Lyons Gary A Director | Facet Biotech Corp (FACT) | 20-Apr-10 | Disposition (change in control) | 8,333 | $27.00 | $224,991.00 | (77%) 10.83K to 2.5K | (< 1%) |
| 21-Apr-10 4:00 PM View: | Emster Kurt von Director | Facet Biotech Corp (FACT) | 20-Apr-10 | Disposition (change in control) | 8,333 | $27.00 | $224,991.00 | (83%) 10.0K to 1.67K | (< 1%) |
| 21-Apr-10 3:56 PM View: | Guggenhime Andrew SVP & CFO | Facet Biotech Corp (FACT) | 20-Apr-10 | Disposition (change in control) | 12,383 | $27.00 | $334,341.00 | (28%) 44.47K to 32.09K | (< 1%) |
| 21-Apr-10 3:55 PM View: | Hasnain Faheem President & CEO Director | Facet Biotech Corp (FACT) | 20-Apr-10 | Disposition (change in control) | 18,463 | $27.00 | $498,501.00 | (15%) 121.13K to 102.67K | (< 1%) |
| 05-Apr-10 5:16 PM View: | Guggenhime Andrew SVP & CFO | Facet Biotech Corp (FACT) | 03-Apr-10 | Payment of Exercise | 1,516 | $26.98 | $40,901.70 | (3%) 45.99K to 44.47K | (< 1%) |
| 09-Feb-10 5:16 PM View: | Bvf Partners L P/il 10% Owner | Facet Biotech Corp (FACT) | 09-Feb-10 | Market Purchase | 19,000 | $15.69 | $298,062.00 | < 1% 23.6M to 23.62M | (1%) |
| 09-Feb-10 5:16 PM View: | Bvf Partners L P/il 10% Owner | Facet Biotech Corp (FACT) | 08-Feb-10 | Market Purchase | 15,200 | $15.37 | $233,562.00 | < 1% 23.55M to 23.56M | < 1% |
| 09-Feb-10 5:16 PM View: | Bvf Partners L P/il 10% Owner | Facet Biotech Corp (FACT) | 05-Feb-10 | Market Purchase | 5,000 | $15.00 | $75,000.00 | < 1% 23.53M to 23.53M | 3% |
| 04-Feb-10 5:34 PM View: | Bvf Partners L P/il 10% Owner | Facet Biotech Corp (FACT) | 04-Feb-10 | Market Purchase | 123,611 | $15.63 | $1,932,260.00 | < 1% 23.11M to 23.24M | 1% |
| 04-Feb-10 5:34 PM View: | Bvf Partners L P/il 10% Owner | Facet Biotech Corp (FACT) | 03-Feb-10 | Market Purchase | 12,138 | $15.80 | $191,780.00 | < 1% 23.01M to 23.02M | (< 1%) |
| 04-Feb-10 5:34 PM View: | Bvf Partners L P/il 10% Owner | Facet Biotech Corp (FACT) | 02-Feb-10 | Market Purchase | 21,000 | $15.80 | $331,800.00 | < 1% 22.95M to 22.97M | (< 1%) |
| 29-Jan-10 5:43 PM View: | Bvf Partners L P/il 10% Owner | Facet Biotech Corp (FACT) | 29-Jan-10 | Market Purchase | 102,000 | $15.72 | $1,603,340.00 | < 1% 22.23M to 22.33M | < 1% |
| 29-Jan-10 5:43 PM View: | Bvf Partners L P/il 10% Owner | Facet Biotech Corp (FACT) | 28-Jan-10 | Market Purchase | 51,600 | $15.70 | $810,311.00 | < 1% 22.04M to 22.09M | < 1% |
| 29-Jan-10 5:43 PM View: | Bvf Partners L P/il 10% Owner | Facet Biotech Corp (FACT) | 27-Jan-10 | Market Purchase | 118,000 | $15.66 | $1,848,280.00 | < 1% 21.73M to 21.85M | < 1% |
| 25-Jan-10 1:58 PM View: | Cross Herb Corp Controller/Prin Acctg Off | Facet Biotech Corp (FACT) | 23-Jan-10 | Payment of Exercise | 1,319 | $15.68 | $20,681.90 | (7%) 18.2K to 16.88K | 0% |
| 22-Jan-10 11:34 AM View: | Llana Ted SVP Commercial & Corporate Dev | Facet Biotech Corp (FACT) | 20-Jan-10 | Payment of Exercise | 2,344 | $17.39 | $40,762.20 | (5%) 45.23K to 42.88K | |
| 22-Dec-09 1:56 PM View: | Cross Herb Corp Controller/Prin Acctg Off | Facet Biotech Corp (FACT) | 19-Dec-09 | Payment of Exercise | 202 | $18.03 | $3,642.06 | (1%) 18.4K to 18.2K | 1% |
| 05-Oct-09 2:41 PM View: | Hasnain Faheem President & CEO Director | Facet Biotech Corp (FACT) | 01-Oct-09 | Payment of Exercise | 8,937 | $17.37 | $155,236.00 | (7%) 128.87K to 119.93K | (2%) |
| 22-Sep-09 5:53 PM View: | Llana Ted SVP, Comm'l & Corp. Dev. | Facet Biotech Corp (FACT) | 21-Sep-09 | Grant | 15,000 | -- | -- | 50% 30.23K to 45.23K | |
| 15-Sep-09 3:12 PM View: | Cross Herb Corp Controller/Prin Acctg Off | Facet Biotech Corp (FACT) | 14-Sep-09 | Payment of Exercise | 1,379 | $16.34 | $22,532.90 | (7%) 19.78K to 18.4K | 0% |
| 15-Sep-09 3:13 PM View: | Sarena Francis Willard VP, Gen Counsel & Secy | Facet Biotech Corp (FACT) | 14-Sep-09 | Payment of Exercise | 1,182 | $16.34 | $19,313.90 | (4%) 26.47K to 25.28K | 0% |
| 09-Sep-09 11:34 AM View: | Huh Hoyoung Director | Facet Biotech Corp (FACT) | 05-Sep-09 | Grant | 8,333 | -- | -- | 100% 0 to 8.33K | |
| 08-Sep-09 5:46 PM View: | Baupost Group Llc/ma 10% Owner | Facet Biotech Corp (FACT) | 04-Sep-09 | Market Sale | 867,532 | $15.43 | $13,382,300.00 | (20%) 4.37M to 3.51M | < 1% |
| 20-Aug-09 5:31 PM View: | Rolfe Mark Sr. Vice Pres. and CSO | Facet Biotech Corp (FACT) | 20-Aug-09 | Grant | 21,333 | -- | -- | 100% 0 to 21.33K | |
| 10-Aug-09 4:03 PM View: | Cross Herb Corp Controller/Prin Acctg Off | Facet Biotech Corp (FACT) | 06-Aug-09 | Grant | 4,500 | -- | -- | 29% 15.28K to 19.78K | |
| 10-Aug-09 4:06 PM View: | Guggenhime Andrew SVP & CFO | Facet Biotech Corp (FACT) | 06-Aug-09 | Grant | 15,251 | -- | -- | 50% 30.74K to 45.99K | |
| 10-Aug-09 4:05 PM View: | Llana Ted SVP, Comm'l & Corp. Dev. | Facet Biotech Corp (FACT) | 06-Aug-09 | Grant | 8,896 | -- | -- | 42% 21.33K to 30.23K | |
| 10-Aug-09 4:04 PM View: | Sarena Francis Willard VP, Gen Counsel & Secy | Facet Biotech Corp (FACT) | 06-Aug-09 | Grant | 6,923 | -- | -- | 38% 18.34K to 25.27K | |
| 10-Aug-09 4:02 PM View: | Hasnain Faheem President & CEO Director | Facet Biotech Corp (FACT) | 06-Aug-09 | Grant | 27,667 | -- | -- | 28% 100.0K to 127.67K | |
| 10-Aug-09 4:06 PM View: | Hora Maninder VP, Prod. Ops. & Quality | Facet Biotech Corp (FACT) | 06-Aug-09 | Grant | 5,325 | -- | -- | 39% 13.59K to 18.92K |
